FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Mylan Pharmaceuticals Rifampin for Injection Recall

Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured fo…

Mylan Pharmaceuticals Inc · Morgantown, WV

Risk level
Class II
Reported by FDA
Apr 27, 2022
Recall ID
D-0774-2022
Check your lot numberHow we source this data

Summary

Mylan Pharmaceuticals recalled Rifampin for Injection starting Apr 7, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0774-2022 on Apr 27, 2022. Reason: Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.

Product description

Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC 67457-445-60

Lot numbers, UPCs & expiration codes

Lot #: 7008990, exp. date Dec-2022; 7009025, exp. date Feb-2023; 7009085, 7009086, exp. date Apr-2023

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0774-2022
Classification
Class II
Status
Terminated
Recall initiated
Apr 7, 2022
FDA report date
Apr 27, 2022
Quantity
33,893 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Mylan Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0774-2022, exactly as published.

Show all FDA fields
City
Morgantown
State
WV
Status
Terminated
Country
United States
Event ID
89910
Address
3711 Collins Ferry Rd
Code information
Lot #: 7008990, exp. date Dec-2022; 7009025, exp. date Feb-2023; 7009085, 7009086, exp. date Apr-2023
Postal code
26505-2362
Report date
Apr 27, 2022
Product type
Drugs
Recall number
D-0774-2022
Classification
Class II
Recalling firm
Mylan Pharmaceuticals Inc
Product quantity
33,893 vials
Termination date
May 23, 2023
Reason for recall
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC 67457-445-60
Distribution pattern
Nationwide in the USA
Recall initiation date
Apr 7, 2022
Initial firm notification
Letter
Center classification date
Apr 15, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0774-2022, published Apr 27, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls